Table 3:
Occurrence of cancers associated with vision loss and the presence of anti-retinal autoantibodies
| Cancer (n=441) | Total (N) | % |
|---|---|---|
| Bladder | 12 | 3% |
| Brain | 7 | 2% |
| Breast | 96 | 22% |
| Colon | 21 | 5% |
| Esophagus | 3 | >1% |
| Gynecological (ovarian, endometrial, uterine, cervical) | 32 | 7% |
| Leukemia | 9 | 2% |
| Liver | 8 | 2% |
| Lung (SCCL, NSCCL, adenocarcinoma) | 47 | 11% |
| Lymphoma | 17 | 4% |
| Melanoma | 82 | 19% |
| Multiple myeloma | 5 | 1% |
| Pancreas | 7 | 2% |
| Pituitary | 5 | 1% |
| Prostate | 30 | 7% |
| Renal | 4 | 1% |
| Sarcoma | 3 | >1% |
| Skin, not melanoma | 14 | 3% |
| Testis | 4 | 1% |
| Thyroid | 16 | 4% |